Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Clinical Trial 20049

Metairie, LA 70006


Study Summary:

A phase 1b/2a, multi-center, double-blind, randomized, placebo-controlled study to evaluate the safety, tolerability, immunogenicity and efficacy in preventing Vulvovaginal Candidiasis in subjects with recurrent Vulvovaginal Candidiasis following administration of a single dose of ndv-3a vaccine, ndv-3 vaccine, or placebo” (the "protocol").


Qualified Participants Must:

• Be 18-50 years of age
• Have a current episode of Yeast
• Have responded to 3 doses oral fluconazole
• Have normal pap smear and be in good health


Qualified Participants May Receive:

Fluconazole and a vaccine injection against Vaginal Candida Albicans and a $100 stipend for each visit to compensate for time and travel.


Research Site Profile

View Clinic Profile